Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Antiviral Therapy|June 22, 2001
Laboratory guidelines for the practical use of HIV drug resistance tests in patient follow-upA M Vandamme, F Houyez, D Bànhegyi, et al.
AIDS Research and Human Retroviruses|June 30, 2000
Presence of 2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5"-(4"-amino-1",2"-oxath iole-2",2"-dioxide) (TSAO)-resistant virus strains in TSAO-inexperienced HIV patientsK Van Laethem, J C Schmit, H Pelemans, et al.
The Journal of Antimicrobial Chemotherapy|March 6, 2015
Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in EuropeJ E Swartz, L Vandekerckhove, H Ammerlaan, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2000
Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analoguesK Van Vaerenbergh, K Van Laethem, J Albert, et al.
Acta Dermatovenerologica Alpina, Pannonica, Et Adriatica|March 11, 2011
HIV-1 drug-resistance patterns among patients on failing treatment in a large number of European countriesD A M C van de Vijver, A M J Wensing, B Åsjö, et al.
Antiviral Therapy|January 18, 2005
Updated European recommendations for the clinical use of HIV drug resistance testingA M Vandamme, A Sönnerborg, M Ait-Khaled, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 2, 2015
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in EuropeL Marije Hofstra, Nicolas Sauvageot, Jan Albert, et al.
Pageof 5